Threat actors are abusing Pastebin comments to distribute a new ClickFix-style attack that tricks cryptocurrency users into ...
Navin Fluorine International share price rose nearly 6 per cent in Tuesday’s trading session after the company reporting over 100 per cent increase in the third-quarter net profit (Q3FY26). The scrip ...
Net profit of Navin Fluorine International rose 121.77% to Rs 185.40 crore in the quarter ended December 2025 as against Rs 83.60 crore during the previous quarter ended December 2024. Sales rose ...
From the moment the first photographs surfaced online, the wedding of Sahil Reddy in Chennai became more than just a family celebration. Images of former Andhra Pradesh Chief Minister Y.S. Jagan Mohan ...
“If you’re carrying 15-20 extra pounds,” it says, “medications like Wegovy can help jumpstart your progress.” ...
Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...
Beginning in 2026, the ACC's Distinguished Award for International Service will be named in honor of Navin C. Nanda, MD, FACC, thanks to the support of the American Association of Cardiologists of ...
Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain territories while leaving the Australian biotech with ownership in key ...
COLUMBIA — It took years for South Carolina legislators to broker a compromise to reform how the General Assembly picks state judges. Now, many of the same lawmakers who helped strike the deal last ...
Dr. Reddy’s Laboratories remains a compelling buy due to underappreciated growth in biosimilars and GLP-1 segments, despite near-term headwinds. RDY's Q2 FY26 results showed modest revenue growth, ...
Navin Girishankar is president of the Economic Security and Technology Department at the Center for Strategic and International Studies (CSIS). He leads a bipartisan team of over 40 resident staff and ...
A pre-approval inspection by the FDA of Dr. Reddy’s Bachupally biologics production facility earlier this month resulted in the drugmaker being issued a Form 483. The FDA reprimand, which was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results